Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

516 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bone-targeted therapy in metastatic breast cancer - all well-established knowledge?
Gampenrieder SP, Rinnerthaler G, Greil R. Gampenrieder SP, et al. Breast Care (Basel). 2014 Oct;9(5):323-30. doi: 10.1159/000368710. Breast Care (Basel). 2014. PMID: 25759612 Free PMC article. Review.
Fulvestrant ('Faslodex') in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme.
Mlineritsch B, Psenak O, Mayer P, Moik M, Namberger K, Hauser-Kronberger C, Greil R. Mlineritsch B, et al. Breast Cancer Res Treat. 2007 Nov;106(1):105-12. doi: 10.1007/s10549-006-9482-7. Epub 2007 Feb 13. Breast Cancer Res Treat. 2007. PMID: 17295045 Clinical Trial.
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).
Mlineritsch B, Tausch C, Singer C, Luschin-Ebengreuth G, Jakesz R, Ploner F, Stierer M, Melbinger E, Menzel C, Urbania A, Fridrik M, Steger G, Wohlmuth P, Gnant M, Greil R; Austrian Breast, Colorectal Cancer Study Group (ABCSG). Mlineritsch B, et al. Breast Cancer Res Treat. 2008 Nov;112(1):203-13. doi: 10.1007/s10549-007-9843-x. Epub 2007 Dec 22. Breast Cancer Res Treat. 2008. PMID: 18158620 Clinical Trial.
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.
Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG; Austrian Fulvestrant Registry. Bartsch R, et al. Breast Cancer Res Treat. 2009 May;115(2):373-80. doi: 10.1007/s10549-008-0132-0. Epub 2008 Jul 26. Breast Cancer Res Treat. 2009. PMID: 18661231 Clinical Trial.
Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Mlineritsch B, Schabel-Moser R, Andel J, Fridrik M, Moik M, Mayer P, Russ G, Rass C, Greil R; Arbeitsgemeinschaft medikamentöse Tumortherapie Study Group. Mlineritsch B, et al. Onkologie. 2009 Feb;32(1-2):18-24. doi: 10.1159/000180915. Epub 2009 Jan 20. Onkologie. 2009. PMID: 19209014 Clinical Trial.
Molecular and cellular mechanisms of CLL: novel therapeutic approaches.
Pleyer L, Egle A, Hartmann TN, Greil R. Pleyer L, et al. Nat Rev Clin Oncol. 2009 Jul;6(7):405-18. doi: 10.1038/nrclinonc.2009.72. Epub 2009 Jun 2. Nat Rev Clin Oncol. 2009. PMID: 19488076 Review.
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, Hüttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. Clin Breast Cancer. 2009 Jun;9 Suppl 1:S18-27. doi: 10.3816/CBC.2009.s.002. Clin Breast Cancer. 2009. PMID: 19561003 Review.
Is Chemoendocrine Treatment without Alternative?
Greil R. Greil R. Breast Care (Basel). 2008;3(4):231-235. doi: 10.1159/000149558. Epub 2008 Aug 22. Breast Care (Basel). 2008. PMID: 21076602 Free PMC article. No abstract available.
516 results
Jump to page
Feedback